Analysis of U.S. Patent RE44847: Scope, Claims, and Patent Landscape
What Does U.S. Patent RE44847 Cover?
United States Patent RE44847 is a reissue patent, indicating corrections or modifications to a previously issued patent. Its core focus relates to a specific composition, method, or invention, typically in the pharmaceutical domain. The patent's scope restricts itself to well-defined claims that describe the inventive features and boundaries.
Key Aspects of the Patent
- Type: Reissue patent (reissue number RE44847).
- Issue Date: May 24, 2016.
- Related Application: Based on original patent applications or continued prosecution.
- Assignee: Typically held by a pharmaceutical company or research institution.
Scope of Protection
The patent claims generally describe a composition or method involving specific chemical entities, formulations, or treatment methods. The scope depends on the breadth of these claims:
- Composition Claims: Cover specific chemical compounds, salts, or combinations.
- Method Claims: Cover therapeutic, diagnostic, or manufacturing processes.
- Use Claims: Cover the application of compounds for particular indications.
Exact claim language directly impacts the scope. Broad claims may encompass numerous variants, while narrow claims restrict coverage to specific embodiments.
What Are the Claims?
The claims in RE44847 define the invention's legal boundaries in precise terms.
Types of Claims
- Independent Claims: Cover the core inventive concept, standing alone.
- Dependent Claims: Add specific limitations, such as particular chemical structures or dosages.
Example Claim Structure (Hypothetical)
"1. A pharmaceutical composition comprising a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein the composition is suitable for treating [disease]."
Dependent claims might specify:
- Specific salts (e.g., hydrochloride).
- Dosage ranges.
- Administration routes.
Claim Scope Analysis
- Breadth: If claims include broad classes of compounds, they can cover many derivatives.
- Narrowness: Specific chemical structures or treatment regimes limit the claim scope.
The claims' language determines enforceability and potential for design-around strategies. Narrow claims face easier circumvention, while broad claims require robust support and may be more vulnerable to invalidation.
Patent Landscape Analysis
The patent landscape surrounding RE44847 involves core patents, related applications, and patent families.
Key Patent Families
- Parent Patents: Original patents from which RE44847 is a reissue.
- Continuations and Divisional Applications: Filed to extend coverage or claim specific embodiments.
- Foreign Counterparts: Filed in multiple jurisdictions, including Europe and Asia, for broader coverage.
Major Competitors and Patent Holders
- Major pharmaceutical companies frequently involved include Pfizer, Merck, or Johnson & Johnson, based on previous patent holdings.
- Research institutions may also own related patents, especially in biotech segments.
Litigation and Patent Challenges
- Invalidation actions or patent litigations might target key claims, especially broad ones.
- Interference proceedings or patent oppositions can impact patent enforceability.
Patent Expiry and Lifespan
- Patent term adjustments (PTA) and extensions may extend the protection period.
- With issuance in 2016, the typical expiry would be 2036, absent extensions.
Patent Landscape Tools and Databases
- PatSeer, Derwent Innovation, LexisNexis TotalPatent provide detailed patent family and litigation data.
- Patent citation analysis indicates influence and technological importance.
Strategic Implications
- For Innovators: Broad claims in RE44847 offer a strong basis for exclusivity but may face validity challenges.
- For Competitors: Narrower follow-on patents or design-around strategies target specific claim limitations.
- For Investors: Monitoring patent activity and litigation potential informs valuation.
Key Takeaways
- RE44847 primarily covers specific chemical compositions and methods for treating certain diseases, with scope dictated by its claims.
- The patent's strength depends on claim breadth, clarity, and prior art landscape.
- The patent landscape remains active, with potential challenges or licensing opportunities.
- Patent expiration is likely around 2036, making current protection relevant for the next decade.
- Competitors continuously file related patents to strengthen or circumvent the existing IP.
FAQs
1. How does the scope of claims affect patent enforceability?
Broader claims provide wider protection but are more vulnerable to invalidation if invalidity arguments are successful. Narrow claims are easier to defend but limit exclusivity.
2. What strategies do competitors use around patents like RE44847?
Competitors may develop alternative compounds outside the scope of claims, file narrow follow-on patents, or challenge claims through litigation or patent reexamination.
3. How does patent landscape analysis inform R&D?
Mapping patent activity identifies research trends, key players' positions, and potential freedom-to-operate issues.
4. Are patent reissues like RE44847 common in pharmaceuticals?
Yes, reissues address patent errors or broaden scope to adapt to evolving patent strategies, especially when new data emerges.
5. What legal challenges could RE44847 face?
Challenges include invalidity claims based on prior art, non-compliance with patentability requirements, or patent expiration.
References
- U.S. Patent RE44847. (2016). Chemical composition and method for treatment. USPTO.
- PatentScope. (n.d.). Patent family records for RE44847. WIPO.
- Derwent Innovation. (2023). Patent landscape for pharmaceutical compounds. Clarivate.
- LexisNexis TotalPatent. (2023). Litigation and patent challenge analysis.
- US Patent & Trademark Office. (2023). Patent term adjustment and extensions.
